Addressing Psychosocial Factors in Cognitive Impairment Screening from a Holistic Perspective: The DeCo-Booklet Methodology Design and Pilot Study

García, Cristina; Royo, Lucrecia Moreno; Alacreu, Mónica; Muñoz-Almaraz, F. J.; Martínez, Luis A.

doi:10.3390/ijerph191912911

Cited by 6 publications

(3 citation statements)

References 104 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Additional tasks for data processing and analysis, which considerably increase the time required per patient, were also considered for the calculations. The details of the whole procedure have been published elsewhere [17].…”

Section: Cognitive Impairment Screening Service (Ciss)mentioning

confidence: 99%

Cost Evaluation of Professional Services in a Rural Community Pharmacy: A Monocentric Exploratory Approach

Martínez,

García,

Moreno

2023

Pharmacy

Self Cite

View full text Add to dashboard Cite

The increasing pressure on healthcare systems (HCSs) is a cause for concern worldwide. Rising costs, uncertainty about sustainability, and aging populations are the main issues that make it challenging to allocate scarce resources to the needs of HCSs. Clinical professional pharmacy services (PSs) have been shown to help alleviate system stress and to reach the entire population, although a cost of provision is borne. The objective of this study was to evaluate the provision costs of three PSs, a medicine-dispensing service (MDS), a multicompartmental compliance aid system service (MCAS), and a cognitive impairment screening service (CISS), in a rural community pharmacy. A cost analysis was performed using a time-driven activity-based costing model. The time dedicated to PS provision was appropriately recorded, and the corresponding expenses were extracted from the accounting records. A provision time of 4.80 min and a cost of EUR 2.24 were estimated for the MDS, while 18.33 min and EUR 8.73 were calculated for the MCAS, and 122.20 min and EUR 56.72 were calculated for the CISS. The total provision time represented 85% of the pharmacist’s effective working time. Tailored cost analysis is a useful tool for making decisions on the implementation of a PS. Larger studies including a variety of pharmacies and locations are necessary to accurately assess costs and engage in discussions on funding and remuneration.

show abstract

Section: Cognitive Impairment Screening Service (Ciss)mentioning

confidence: 99%

Cost Evaluation of Professional Services in a Rural Community Pharmacy: A Monocentric Exploratory Approach

Martínez,

García,

Moreno

2023

Pharmacy

Self Cite

View full text Add to dashboard Cite

show abstract

“…Además, se ha propuesto que aspectos como la resiliencia y el aislamiento social, así como ciertos constructos de carácter motivacional y cognitivo podrían influir notablemente en el proceso de EvS y, por tanto, en la aparición de DC (29). El diseño de un cuestionario que contemple estas variables y permita establecer asociaciones estadísticas entre ellas y su relación con el DC ofrece un campo de gran interés para el desarrollo de futuros proyectos de mayor entidad (30).…”

Section: Factores Psicosocialesunclassified

Estudio de los factores de riesgo de deterioro cognitivo en el medio rural: metodología y pilotaje desde la farmacia comunitaria

Martínez¹,

García²,

Moreno³

2023

View full text Add to dashboard Cite

Introducción: el deterioro cognitivo está mediado por la exposición a una gran variedad de factores de riesgo, entre los que la edad es el más relevante. El fenómeno global del envejecimiento de la población hace que conseguir separar los conceptos de envejecimiento y enfermedad sea una tarea de gran interés. En España, la población rural es un estrato particularmente envejecido que puede tener dificultades de acceso a los servicios sanitarios. Las farmacias comunitarias están ampliamente distribuidas en nuestra geografía y el farmacéutico es el sanitario más accesible para esta población tan vulnerable.Métodos: se ha diseñado y pilotado una metodología para evaluar el deterioro cognitivo y el envejecimiento saludable desde la farmacia comunitaria en nuestro medio, utilizando un cuestionario ad hoc compuesto por tests validados para población española, dividido en cinco secciones: deterioro cognitivo, factores sociodemográficos, problemas de salud, estilo de vida y factores psicosociales.Resultados: la prevalencia encontrada para el deterioro cognitivo y el envejecimiento saludable fue de 28,2 % y 15,4 %, respectivamente. La prevalencia (o el valor medio poblacional) calculado para factores de riesgo o factores protectores de deterioro cognitivo resultó compatible con los datos publicados para población española. Los resultados mostraron que este cuestionario puede resultar adecuado para la recogida de información acerca de las variables relacionadas con el deterioro cognitivo en nuestro entorno.Conclusión: el estudio de la influencia de cada factor sobre el deterioro cognitivo debe ser abordado con detalle debido a las complejas interrelaciones existentes entre ellos. En este sentido, las variables más novedosas, como son los factores psicosociales, deben constituir uno de los objetivos prioritarios.

show abstract

“…The joint assessment of the influence of psychosocial, clinical, and lifestyle-related variables provides relevant information for the CI course analysis. These include physical activity, nutrition, social interaction, and occupation (García et al, 2022 ).…”

Section: Introductionmentioning

confidence: 99%

The A-to-Z factors associated with cognitive impairment. Results of the DeCo study

Gil-Peinado,

Alacreu,

Ramos

et al. 2023

Front. Psychol.

Self Cite

View full text Add to dashboard Cite

IntroductionCognitive impairment (CI) is known to be mediated by several risk and protective factors, many of which are potentially modifiable. Therefore, it is important to have up-to-date studies that address a standard assessment of psychosocial, clinical and lifestyle variables.Materials and methodsWe conducted a cross-sectional observational study, with a 24-month timeframe, to estimate the relationship between risk and protective factors associated with dementia, according to the A-to-Z Dementia Knowledge. Participants were considered at CI risk if they tested positive for at least one of three validated CI screening tests: The Memory Impairment Screening, Short Portable Mental State Questionnaire, and Semantic Verbal Fluency. The A-to-Z data Collection included Mediterranean Diet Adherence Screener and Geriatric Depression Scale.ResultsThe estimated prevalence of CI was 22.6% in a sample of 709 patients with an average of 69.3±10.3 years. The risk factors gradually associated with cognitive decline were hypertension, loneliness, and depression. In contrast, the protective factors gradually associated with less cognitive decline were internet use, reading, and intellectually stimulating jobs. Finally, living alone, having diabetes, taking benzodiazepines, and sleeping more than 9 h were statistically significant associated with CI, whereas to do memory training or a family history of dementia was characteristic of patients without CI.ConclusionA joint assessment of the influence of psychosocial, clinical, and lifestyle-related factors is needed to develop dementia prevention strategies.

show abstract

Addressing Psychosocial Factors in Cognitive Impairment Screening from a Holistic Perspective: The DeCo-Booklet Methodology Design and Pilot Study

Cited by 6 publications

References 104 publications

Cost Evaluation of Professional Services in a Rural Community Pharmacy: A Monocentric Exploratory Approach

Cost Evaluation of Professional Services in a Rural Community Pharmacy: A Monocentric Exploratory Approach

Estudio de los factores de riesgo de deterioro cognitivo en el medio rural: metodología y pilotaje desde la farmacia comunitaria

The A-to-Z factors associated with cognitive impairment. Results of the DeCo study

Contact Info

Product

Resources

About